COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY INC.Predictive Oncology Inc. • February 7th, 2020 • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of that certain senior secured convertible promissory note dated February 5, 2020, in the original principal amount of up to $1,450,000.00 by the Company (as defined below) to the Lender (as defined below)) (the “Note”), Oasis Capital, LLC, a Puerto Rico limited liability company (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to 94,631 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by
SECURITY AGREEMENTSecurity Agreement • February 7th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS SECURITY AGREEMENT (this “Agreement”), dated as of February 5, 2020, is by and between PREDICTIVE ONCOLOGY INC., a Delaware corporation (the “Grantor”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (the “Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 5, 2020, (the “Execution Date”), is entered into by and between PREDICTIVE ONCOLOGY INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (the “Buyer”).
